Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of HAS2 mRNA | affects expression | 16483693
|
C015001 |
arsenite |
[arsenite co-treated with Benzo(a)pyrene] results in decreased expression of HAS2 mRNA | affects cotreatment|decreases expression | 15894712
|
C015001 |
arsenite |
arsenite results in decreased expression of HAS2 mRNA | decreases expression | 15894712 18929588
|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite results in increased expression of HAS2 mRNA | increases expression | 18687144
|
D001564 |
Benzo(a)pyrene |
[arsenite co-treated with Benzo(a)pyrene] results in decreased expression of HAS2 mRNA | affects cotreatment|decreases expression | 15894712
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of HAS2 mRNA | decreases expression | 15894712
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of HAS2 mRNA | decreases expression | 20382639
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased expression of HAS2 mRNA | increases expression | 15336504
|
C402665 |
CP 31398 |
CP 31398 results in increased expression of HAS2 mRNA | increases expression | 15155752
|
C014347 |
decitabine |
decitabine affects the expression of HAS2 mRNA | affects expression | 17145863
|
D002117 |
Calcitriol |
Calcitriol results in increased expression of HAS2 mRNA | increases expression | 16002434
|
D004958 |
Estradiol |
ESR1 protein affects the reaction [Estradiol results in decreased expression of HAS2 mRNA] | affects reaction|decreases expression | 14699072
|
D004958 |
Estradiol |
Estradiol affects the expression of HAS2 mRNA | affects expression | 14699072
|
D006820 |
Hyaluronic Acid |
HAS2 protein results in increased chemical synthesis of Hyaluronic Acid | increases chemical synthesis | 11318944
|
D006820 |
Hyaluronic Acid |
[IL1B protein results in increased expression of HAS2 protein] which results in increased chemical synthesis of Hyaluronic Acid | increases chemical synthesis|increases expression | 11318944
|
C025299 |
polyphenols |
polyphenols results in decreased expression of HAS2 mRNA | decreases expression | 16293270
|
D020849 |
Raloxifene |
[Raloxifene co-treated with ESR1 protein] results in decreased expression of HAS2 mRNA | affects cotreatment|decreases expression | 19059307
|
C009277 |
sodium arsenate |
sodium arsenate results in increased expression of HAS2 mRNA | increases expression | 16882884
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of HAS2 mRNA | decreases expression | 18812580
|
D013605 |
T-2 Toxin |
T-2 Toxin results in decreased expression of HAS2 mRNA | decreases expression | 18196609
|
D013629 |
Tamoxifen |
[Tamoxifen co-treated with ESR1 protein] results in decreased expression of HAS2 mRNA | affects cotreatment|decreases expression | 19059307
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of HAS2 mRNA | decreases expression | 16443690
|
D014212 |
Tretinoin |
Tretinoin promotes the reaction [CREBBP protein binds to HAS2 promoter] | affects binding|increases reaction | 17307735
|
D014212 |
Tretinoin |
Tretinoin promotes the reaction [MED1 protein binds to HAS2 promoter] | affects binding|increases reaction | 17307735
|
D014212 |
Tretinoin |
Tretinoin promotes the reaction [NCOA3 protein binds to HAS2 promoter] | affects binding|increases reaction | 17307735
|
D014212 |
Tretinoin |
Tretinoin promotes the reaction [SP1 protein binds to HAS2 promoter] | affects binding|increases reaction | 17307735
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of HAS2 mRNA | increases expression | 17307735
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of HAS2 mRNA | increases expression | 16604517
|
C101044 |
tyrphostin AG 1478 |
tyrphostin AG 1478 inhibits the reaction [LHB protein results in increased expression of HAS2 mRNA] | decreases reaction|increases expression | 15459120
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.47 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.76 | 15322242 14514962 11752688 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.47 | 18287403 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
4.21 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
4.21 | 11473722 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.60 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.29 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.62 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.82 | 16712894 17306315 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
4.51 | 17451421 17308373 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.54 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
2.52 | 15800139 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.87 | 11748828 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.99 | 19183758 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.02 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.24 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.32 | 16456186 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.32 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.66 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
8.66 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.71 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.71 | 15746008 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.39 | 16580743 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
4.67 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
4.67 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
4.67 | 19208741 18320071 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
4.67 | 12948864 19861407 17289903 17018787 14630087 17261762 18497071 16675129 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
4.67 | 17261762 17595753 17952589 17440819 17049068 15775269 15572757 17242785 15758505 16837676 16912660 17893378 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
4.67 | 20135344 19487384 18351453 21138602 18855134 18821012 19115204 20390343 11161223 18984771 19084267 19244106 15668708 19142967 19011961 17440819 19155303 20065188 18629630 18997820 16202921 21152245 19189210 19289846 19221464 19200415 17893378 19410462 20544844 16818667 19189212 16873071 18815881 19066611 15565566 17261762 20859285 20005174 19059307 16273361 17049068 19103187 17242785 19288272 18425577 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
4.67 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
4.67 | 16166294 16443354 16873071 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
tyrphostin AG 1478 |
4.81 | 12794006 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.50 | 16813970 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.38 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.73 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.42 | 19066611 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.08 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
6.47 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
6.47 | 16507464 17306315 15276417 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
6.47 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
6.47 | 1917145 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
14.07 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
14.07 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
14.07 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
14.07 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
14.07 | 16096774 16051514 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
9.23 | 17572228 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
9.23 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.32 | 18850075 18670907 16120746 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
3.38 | 15775269 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.04 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
10.84 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
10.84 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
10.84 | 20056578 19524636 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.50 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.08 | 16835633 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.08 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.64 | 15340226 12621046 8697196 15668235 16354765 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.64 | 9407595 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.53 | 15800139 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.62 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
arsenite |
5.89 | 15037631 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
5.89 | 17616700 |
MESH:D003110 |
Colonic Neoplasms |
|
polyphenols |
5.89 | 16293270 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.10 | 18981723 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.98 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
sodium arsenate |
3.82 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.82 | 10048152 20055451 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
3.82 | 10589399 9664655 17551590 14991402 16925845 9142499 9224671 9211117 8800419 9125849 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.28 | 19031437 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
4.08 | 17474826 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.65 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
14.58 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
14.58 | 15920148 17451421 17308373 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
14.58 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
polyphenols |
6.26 | 19370779 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
sodium arsenate |
6.26 | 18186108 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.26 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.69 | 11462148 |
MESH:D004487 |
Edema |
|
Raloxifene |
6.58 | 15860553 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.58 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
11.67 | 15322242 16714409 18230668 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
11.67 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
14.96 | 15138306 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
14.96 | 15845917 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
14.96 | 19031437 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
5.03 | 19294695 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
12.09 | 19148513 18566989 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
12.09 | 16202921 17893378 20544844 19155303 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
12.09 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.94 | 10568697 9294722 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.27 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.27 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.61 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.61 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
arsenite |
12.81 | 18296743 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
12.81 | 17473493 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
12.81 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.18 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.37 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.44 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.10 | 19069698 |
MESH:D005355 |
Fibrosis |
|
arsenite |
14.34 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
14.34 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
14.34 | 17994277 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.59 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
2.95 | 17312396 |
MESH:D018149 |
Glucose Intolerance |
|
sodium arsenate |
5.00 | 19446573 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.51 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
7.63 | 19215824 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
7.63 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.08 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
10.82 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
10.82 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
10.82 | 9664655 14991402 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
3.47 | 11110106 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.25 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.81 | 16120746 15340226 12621046 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.95 | 15709030 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.08 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.67 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.96 | 8697196 16354765 15340226 16959395 18606429 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.14 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.48 | 16778211 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
5.12 | 17577099 15787275 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.12 | 18850075 18670907 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
6.71 | 17581917 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
6.71 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
polyphenols |
8.09 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
8.09 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
8.09 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
2.91 | 16627594 16393666 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.68 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
9.66 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
9.66 | 15992940 17551590 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
5.94 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
5.94 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
7.14 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
7.14 | 18625569 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.41 | 16973256 |
MESH:D007938 |
Leukemia |
|
decitabine |
6.28 | 18980019 19235587 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
6.28 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
9.29 | 18454857 19117987 17236224 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
9.29 | 19285840 16482212 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
3.92 | 19010910 18704418 18460780 18206229 17679729 19387464 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
3.92 | 19850784 16294345 17596541 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.38 | 18055864 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.09 | 17294898 17506722 16788101 16935935 16823087 16140955 9834237 16331271 17712046 17368321 19642359 19225113 17649720 15748426 17339181 16766008 17361223 17301526 19035177 19029980 19075265 17107899 16891316 17217047 12679006 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.24 | 9224671 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.09 | 17567588 15342952 |
MESH:D008103 |
Liver Cirrhosis |
|
arsenite |
3.37 | 18296743 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
4.85 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
4.85 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
4.85 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
4.85 | 16248980 18397230 |
MESH:D008107 |
Liver Diseases |
|
polyphenols |
2.76 | 16698588 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
10.41 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
10.41 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
10.41 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
10.41 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.05 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.11 | 19095001 |
MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
3.94 | 17365036 |
MESH:D008175 |
Lung Neoplasms |
|
arsenite |
6.47 | 16809336 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
6.47 | 18569708 20064080 18816296 17053015 20464547 20869020 18520028 6695378 20135361 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
6.47 | 17306315 17077188 16712894 19931552 15276417 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
6.47 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
6.47 | 11884234 19555203 |
MESH:D008223 |
Lymphoma |
|
decitabine |
3.35 | 19470736 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.67 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
5.78 | 11408345 11807958 17203775 16891317 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
5.78 | 19196723 14580682 16827153 11731420 19196722 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
12.38 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
12.38 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.75 | 17453147 |
MESH:D008545 |
Melanoma |
|
decitabine |
7.18 | 17785578 16505122 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
7.18 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
7.18 | 12393984 19393235 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
7.18 | 16752155 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.10 | 15990972 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.34 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
3.15 | 18303189 16966607 16166281 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.47 | 15863610 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.12 | 16381670 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
7.29 | 18172295 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
7.29 | 16497877 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
sodium arsenate |
4.77 | 18186108 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
7.31 | 19157545 16882708 19010910 18608210 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
7.31 | 17596541 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.95 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.21 | 16810080 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.47 | 16343187 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.51 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.49 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
11.52 | 11141357 |
MESH:D009369 |
Neoplasms |
|
decitabine |
11.52 | 19470736 19116145 17925555 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
11.52 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
11.52 | 16946489 16594593 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.58 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.92 | 19200415 19189210 19196722 |
MESH:D009389 |
Neovascularization, Pathologic |
|
arsenite |
9.87 | 15738583 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
9.87 | 17289903 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
15.83 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
15.83 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
15.83 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenate |
11.93 | 19446573 18186108 11749123 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
11.93 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
11.93 | 9142499 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
3.34 | 17882678 15775268 19059307 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
4.14 | 17823083 15579764 17893378 15758505 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
11.08 | 19259094 19331143 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
11.08 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
11.08 | 17306315 15276417 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
11.08 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
2.83 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
5.27 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
5.27 | 15976015 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.17 | 12520081 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
4.81 | 10923243 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.47 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.11 | 11118676 11222880 11896295 11399792 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.64 | 17616702 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
4.69 | 15572423 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.80 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.09 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
2.09 | 16289102 18247401 15754350 12479363 16644109 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.09 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Hyaluronic Acid |
2.09 | 16864594 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
2.09 | 16220300 16536755 15731164 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.09 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.09 | 15067354 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.52 | 16636307 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.71 | 16723453 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
3.00 | 17322281 17365031 17975199 15814490 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.47 | 15770314 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.75 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
10.67 | 19155313 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
10.67 | 16283617 16116481 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
17.48 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
17.48 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
17.48 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
17.48 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
17.48 | 16467112 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
4.21 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.95 | 19457130 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.73 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
3.33 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
3.33 | 19037991 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
3.33 | 17261132 |
MESH:D020521 |
Stroke |
|
Raloxifene |
3.75 | 16837676 |
MESH:D013705 |
Temporomandibular Joint Disorders |
|
polyphenols |
5.17 | 17997062 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.82 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
7.07 | 17967635 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
7.07 | 17045167 16026305 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
13.44 | 19048282 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
13.44 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.71 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.17 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
15.45 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
15.45 | 17616700 19087683 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
15.45 | 17572228 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
15.45 | 17306315 16452187 16712894 11723127 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
15.45 | 16712894 17572228 8653321 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
9.15 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
9.15 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
12.56 | 17785578 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
12.56 | 16752155 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.34 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.51 | 12125929 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
5.13 | 16837676 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.97 | 16761959 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.47 | 16343187 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.17 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.89 | 16287080 |